Congress Materials - Society of Urologic Nurses and Associates (SUNA 2025)
2025 Society of Urologic Nurses and Associates | Oct 10-13 | Louisville, KY
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
SunRISe-1: Updated Study Results From Cohorts 2 and 4 and Multidisciplinary Team Perspectives on Gemcitabine Intravesical System Treatment of High-Risk Non–Muscle-Invasive Bladder Cancer
Mary Hoyt, Chrisine Feliu, Nicole Osimo, Joseph Jacob, Siamak Daneshmand, Neal Shore
This document will be available on October 10th 2025
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.
